Drug Side Effects
Search
NON-SMALL CELL LUNG CANCER STAGE II
NON-SMALL CELL LUNG CANCER STAGE II
was reported 19 times
These drug classes are most commonly taken by patients reporting NON-SMALL CELL LUNG CANCER STAGE II:
#
Drug
Count
0
Corticosteroid [EPC]
6
1
Tumor Necrosis Factor Blocker [EPC]
5
2
Folate Analog Metabolic Inhibitor [EPC]
3
3
Loop Diuretic [EPC]
3
4
Proton Pump Inhibitor [EPC]
3
5
Nonsteroidal Anti-inflammatory Drug [EPC]
2
6
Thalidomide Analog [EPC]
2
7
Aminosalicylate [EPC]
1
8
Anti-epileptic Agent [EPC]
1
9
Atypical Antipsychotic [EPC]
1
10
Azole Antifungal [EPC]
1
11
Benzodiazepine [EPC]
1
12
Central alpha-2 Adrenergic Agonist [EPC]
1
13
Estrogen [EPC]
1
14
Fluoroquinolone Antibacterial [EPC]
1
15
GLP-1 Receptor Agonist [EPC]
1
16
Glycopeptide Antibacterial [EPC]
1
17
Janus Kinase Inhibitor [EPC]
1
18
Leukocyte Growth Factor [EPC]
1
19
Lipid-based Polyene Antifungal [EPC]
1
20
Mood Stabilizer [EPC]
1
21
Nucleoside Analog Antiviral [EPC]
1
22
Nucleoside Metabolic Inhibitor [EPC]
1
23
Penem Antibacterial [EPC]
1
24
Platinum-based Drug [EPC]
1
25
Polyene Antifungal [EPC]
1
26
Prostacycline Vasodilator [EPC]
1
27
Proteasome Inhibitor [EPC]
1
28
beta-Adrenergic Blocker [EPC]
1